David Lau
发表
N. Pavlakis,
D. Haller,
M. Peeters,
2020,
Expert review of anticancer therapy.
G. Abou-Alfa,
I. Chau,
M. Javle,
2020,
Cancer treatment reviews.
Laura M. Jenkins,
A. Weickhardt,
David Lau,
2019,
Cancer drug resistance.
I. Chau,
David Lau,
J. Mencel,
2022,
Expert opinion on drug safety.
J. Mariadason,
T. Price,
N. Tebbutt,
2018,
British Journal of Cancer.
O. Sieber,
J. Mariadason,
T. Limpaiboon,
2019,
iScience.
J. Furuse,
N. Tebbutt,
M. Zalupski,
2022,
Frontiers in Oncology.
J. Mariadason,
A. Weickhardt,
David Lau,
2021,
BMC Cancer.
N. Starling,
David Lau,
Anderley Gordon,
2022,
OncoTargets and therapy.
N. Starling,
David Lau,
Anderley Gordon,
2022
.
A. Scott,
J. Mariadason,
N. Tebbutt,
2017,
Molecular oncology.
J. Larkin,
L. Pickering,
C. Swanton,
2021
.
M. Gerlinger,
H. Pandha,
I. Tomlinson,
2019,
Journal of Clinical Oncology.
M. Gerlinger,
T. Lund,
K. Fenwick,
2022,
bioRxiv.
T. Price,
N. Tebbutt,
F. Chionh,
2017,
The Cochrane database of systematic reviews.
I. Davis,
J. Cebon,
M. Andrews,
2014,
Melanoma research.
J. Mariadason,
N. Pavlakis,
N. Tebbutt,
2021,
Molecular Cancer Therapeutics.
M. Gerlinger,
H. Pandha,
I. Tomlinson,
2020,
ESMO Open.
L. Pickering,
K. Edmonds,
R. Wilkinson,
2021,
Nature Medicine.
S. Krishna,
M. Aresu,
H. Staines,
2022,
The oncologist.
M. Hubank,
I. Chau,
C. Fribbens,
2023,
BMC Cancer.
I. Chau,
David Lau,
A. Athauda,
2021,
Expert opinion on pharmacotherapy.
J. Mariadason,
T. Price,
N. Tebbutt,
2018,
British Journal of Cancer.
A. Weickhardt,
David Lau,
Natalia Vukelic,
2021
.